DA 5216
Alternative Names: DA-5216Latest Information Update: 26 Aug 2022
At a glance
- Originator Dong-A ST
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Unspecified
Most Recent Events
- 24 Aug 2022 Dong-A ST plans a phase I pharmacokinetics trial (In volunteers) in South Korea (NCT05506007)
- 18 Aug 2022 Preclinical trials in Unspecified in South Korea (unspecified route) prior to August 2022 (NCT05506007)